Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...

Kennedy has made false claims that vaccines are linked to autism, which the science does not support. He says he is not ...

That locked up the obesity drug. But after 9 Meters started ... Wegovy, for example, "doesn't really work" — at least to the Food and Drug Administration standard of weight loss of 5% or more ...

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...

Kennedy possibly to follow at the Department of Health and Human Services, it’s hard to say what’s in store for the Food and Drug Administration ... the fight against obesity — would ...

When it comes to ages 12 to 18 who are dealing with obesity, Americans are divided ... surged in popularity after the Food and Drug Administration approved them for weight loss in 2021. Now, they’re ...